These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25855800)

  • 1. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
    Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
    Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
    Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
    Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
    Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
    J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the MIR34B/C in multiple myeloma.
    Wong KY; Yim RL; So CC; Jin DY; Liang R; Chim CS
    Blood; 2011 Nov; 118(22):5901-4. PubMed ID: 21976676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of MIR203 in multiple myeloma.
    Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
    Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
    Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
    Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
    J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c.
    Guo X; Jing C; Li L; Zhang L; Shi Y; Wang J; Liu J; Li C
    Biochem Biophys Res Commun; 2011 Jan; 404(2):622-7. PubMed ID: 21156161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
    PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
    Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
    Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.